NeuroRisk AI â€“ Post-COVID Brain Fog Screening Tool

An explainable machine learning-based clinical decision support prototype designed to assist in early screening of post-COVID cognitive impairment risk.

ğŸ“Œ Problem Statement

Post-COVID patients often report cognitive symptoms such as â€œbrain fog,â€ fatigue, and mental health disturbances. However, early identification of high-risk individuals remains challenging in clinical settings.

NeuroRisk AI is a lightweight, interpretable ML prototype that estimates the probability of brain fog occurrence using structured health data.

This tool is designed for:

Early screening

Risk stratification

Clinical monitoring support

âš ï¸ This is a screening support tool, not a diagnostic system.

ğŸ“Š Dataset

Size: 500 Ã— 12

Target: Brain Fog (Yes/No)

Features:

Demographics

COVID severity

Fatigue level

Mental health impact

Physical activity level

Recovery duration

Long COVID indicators

Class distribution:

25% Brain Fog (Yes)

75% Brain Fog (No)

ğŸ§  Model Architecture

Model Used: Logistic Regression
Why Logistic Regression?

Interpretable

Clinically explainable

Suitable for small tabular datasets

Transparent coefficient analysis

Preprocessing:

One-hot encoding for categorical features

Standard scaling for numeric features

Class-weight balancing

5-fold cross-validation

Threshold optimization for recall prioritization

ğŸ“ˆ Model Performance

Cross-validated ROC-AUC â‰ˆ 0.60

Recall optimized for screening sensitivity

Probability range: 0.16 â€“ 0.89

This performance reflects moderate predictive separation typical of small clinical datasets.

ğŸ” Explainability (SHAP Integration)

Global feature drivers identified:

Fatigue Level

Mental Health Impact

COVID Severity

Days to Recovery

Physical Activity Level

Local patient-level explanations provided via SHAP force plots.

This ensures:

Transparency

Trust

Clinical interpretability

ğŸ¥ Product Features

âœ” Risk Score (0â€“100%)
âœ” Risk Category (Low / Moderate / High)
âœ” Colored risk visualization
âœ” Clinical recommendation logic
âœ” Interactive notebook-based UI (Colab)
âœ” SHAP feature attribution panel

ğŸ’¡ Example Output

Risk Score: 58.4%
Risk Category: MODERATE

Key Contributors:

Elevated fatigue level

Moderate COVID severity

Extended recovery duration

Recommended Action:
Monitor cognitive symptoms over the next 2â€“4 weeks.

ğŸ— System Flow

Raw Data
â†’ Preprocessing
â†’ Logistic Regression
â†’ Probability Scoring
â†’ SHAP Explainability
â†’ Risk Dashboard Output

âš ï¸ Limitations

Dataset limited to 500 samples

No longitudinal clinical markers

No lab/imaging data

Not externally validated

Intended for educational and prototype purposes only

ğŸš€ Future Improvements

Larger clinical dataset

Longitudinal modeling

XGBoost/CatBoost comparison

API deployment (FastAPI)

Streamlit cloud deployment

PDF risk report export
